100 related articles for article (PubMed ID: 6656850)
1. Drug-induced reversal of early diabetic microangiopathy.
Camerini-Davalos RA; Velasco C; Glasser M; Bloodworth JM
N Engl J Med; 1983 Dec; 309(25):1551-6. PubMed ID: 6656850
[TBL] [Abstract][Full Text] [Related]
2. Sulfonylurea-induced decrease of muscle capillary basement membrane thickness in diabetes.
Camerini-Davalos RA; Velasco CA; Glasser M; Bloodworth JM
Diabetes Res Clin Pract; 1988 Jul; 5(2):113-23. PubMed ID: 3046878
[TBL] [Abstract][Full Text] [Related]
3. Glipizide for reversal of early diabetic microangiopathy.
N Engl J Med; 1984 May; 310(21):1389-90. PubMed ID: 6717514
[No Abstract] [Full Text] [Related]
4. Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients.
Siperstein MD; Unger RH; Madison LL
J Clin Invest; 1968 Sep; 47(9):1973-99. PubMed ID: 5675423
[TBL] [Abstract][Full Text] [Related]
5. Absence of capillary microangiopathy in oral contraceptive users with glucose intolerance.
Goldzieher JW; Villegas-Castrejon H; Cervantes A; Maqueo M; Siperstein MD
Obstet Gynecol; 1978 Jan; 51(1):89-92. PubMed ID: 619342
[TBL] [Abstract][Full Text] [Related]
6. The various faces of diabetes in the young: changing concepts.
Fajans SS; Floyd JC; Tattersall RB; Williamson JR; Pek S; Taylor CI
Arch Intern Med; 1976 Feb; 136(2):194-202. PubMed ID: 1247351
[TBL] [Abstract][Full Text] [Related]
7. Effect of insulin-glipizide combination on skeletal muscle capillary basement membrane width in diabetic patients.
Camerini-Davalos RA; Bloodworth JM; Velasco CA; Reddi AS
Clin Ther; 1994; 16(6):952-61. PubMed ID: 7697692
[TBL] [Abstract][Full Text] [Related]
8. Delay of progression of diabetic microangiopathy.
Camerini-Davalos RA; Velasco CA; Reddi AS; Glasser M; Bloodworth JM
Metabolism; 1988 Feb; 37(2 Suppl 1):10-8. PubMed ID: 2963192
[TBL] [Abstract][Full Text] [Related]
9. Prospective studies of muscle capillary basement membrane width in prediabetics.
Feingold KR; Browner WS; Siperstein MD
J Clin Endocrinol Metab; 1989 Oct; 69(4):784-9. PubMed ID: 2778035
[TBL] [Abstract][Full Text] [Related]
10. Enzyme activities as a predictor of diabetic vasculopathy.
Camerini-Davalos RA; Velasco CA; Glasser M; Bloodworth JM
Am J Med; 1986 Apr; 80(4):574-82. PubMed ID: 2938472
[TBL] [Abstract][Full Text] [Related]
11. Long-term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose tolerance.
Eriksson JG; Lehtovirta M; Ehrnström B; Salmela S; Groop L
J Intern Med; 2006 Jun; 259(6):553-60. PubMed ID: 16704555
[TBL] [Abstract][Full Text] [Related]
12. Morphometric evaluation of capillary basement membrane thickness in the quadriceps muscle of diabetic and nondiabetic Chinese hamsters.
Sawada G; Wyse BM; Blanks MC; Vidmar TJ; Gerritsen GC; Diani AR
Histol Histopathol; 1986 Jan; 1(1):1-8. PubMed ID: 2980097
[TBL] [Abstract][Full Text] [Related]
13. Studies of kidney and muscle biopsy specimens from identical twins discordant for type I diabetes mellitus.
Steffes MW; Sutherland DE; Goetz FC; Rich SS; Mauer SM
N Engl J Med; 1985 May; 312(20):1282-7. PubMed ID: 4039409
[TBL] [Abstract][Full Text] [Related]
14. Sustained-release versus immediate-release glipizide for treatment of type 2 diabetes mellitus in chinese patients: A randomized, double-blind, double-dummy, parallel-group, 12-week clinical study.
Hsieh SH; Lin JD; Cheng HY; Ho C; Liou MJ
Clin Ther; 2006 Sep; 28(9):1318-26. PubMed ID: 17062305
[TBL] [Abstract][Full Text] [Related]
15. Diabetic microangiopathy: electron microscope findings in human muscle.
Siperstein MD
Adv Metab Disord; 1973; 2():Suppl 2:349-55. PubMed ID: 4720371
[No Abstract] [Full Text] [Related]
16. [Clinical efficacy of a Minidiab preparation (glipizide) in an acute experiment].
Borisova AM; Taneva T; Koev D; Georgieva R
Vutr Boles; 1988; 27(2):85-9. PubMed ID: 3137730
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacology of S-1702. Its action on glycemia and the microvascular system of normal and diabetic animals].
Duhault J; Lebon F; Boulanger M
Journ Annu Diabetol Hotel Dieu; 1971 May; 12(0):257-60. PubMed ID: 5164767
[No Abstract] [Full Text] [Related]
18. A morphometric analysis of the capillary basement membrane as a diagnostic parameter in diabetes mellitus.
Martínek J; Krausová Z
Funct Dev Morphol; 1991; 1(1):35-8. PubMed ID: 1793985
[TBL] [Abstract][Full Text] [Related]
19. Reduction in use of healthcare services with combination sulfonylurea and rosiglitazone: findings from the Rosiglitazone Early vs SULfonylurea Titration (RESULT) study.
Herman WH; Dirani RG; Horblyuk R; O'Neill MC; Kravitz B; Heise MA; Bakst A; Freed MI;
Am J Manag Care; 2005 Apr; 11(4):273-8. PubMed ID: 15839187
[TBL] [Abstract][Full Text] [Related]
20. Diabetic microangiopathy and the control of blood glucose.
Siperstein MD
N Engl J Med; 1983 Dec; 309(25):1577-9. PubMed ID: 6656851
[No Abstract] [Full Text] [Related]
[Next] [New Search]
